BDBM224226 6-(5-chloropyridin-3- yl)-7-[(trans-4- methylcyclohexyl) methyl]-8-[2-(3-methyl- 1,2,4-oxadiazol-5- yl)pyrrolidin-1-yl]- 7h-purine-2- carboxylic acid (racemate)::US9540377, 16.145

SMILES Cc1noc(C2CCCN2c2nc3nc(C(=O)O)nc(-c4cncc(Cl)c4)c3n2C[C@H]2CC[C@H](C)CC2)n1

InChI Key InChIKey=QDKPVDBVVFZWSM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224226   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224226BDBM224226(US9540377, 16.145 | 6-(5-chloropyridin-3- yl)-7-[(...)
Affinity DataIC50: 3.92nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent